Search
STAAR Surgical Co
STAAAdd to Watchlist
23.140USD
+0.070+0.30%
Close 08-21 16:00（ET）
1.16BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-21The current earnings forecast score of STAAR Surgical Co is 6.50, ranking 161 out of 198 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 30.75 and a low of 16.00.
Analyst Rating
Based on
12
analysts
Hold
Current Rating
27.900
Target Price
+20.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
STAAR Surgical Co
STAA
12
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Zimmer Biomet Holdings Inc
ZBH
29
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is STAAR Surgical Co's expected revenue for the next quarter?
STAAR Surgical Co's expected revenue is 79.38M.
What is STAAR Surgical Co's price target?
Analysts forecast that STAAR Surgical Co's price target is USD 28.00, with the highest forecast at USD 30.75 and the lowest forecast at USD 16.00.
How have STAAR Surgical CoSTAA's recent earnings per share performed?
The market expectation was USD 0.16, while STAAR Surgical CoSTAA's earnings per share (EPS) for the previous quarter was USD 0.10. EPS for the next quarter is expected at USD 0.07.
What is the analyst rating for STAAR Surgical Co?
Based on the ratings of STAAR Surgical Co's stock from 12 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.